Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine for liver function protection after open heart surgery
IRCT20190506043492N2Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of acetylcysteine in Hepatic ischemia (IH) (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoints: Postoperative serum alkaline phosphatase, Postoperative serum aspartate aminotransferase and 3 more. Started Sep 2018; status: completed.
02
Drugs
acetylcysteine
03
Conditions
Hepatic ischemia (IH)
Beyond the preview
Go deeper on IRCT20190506043492N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190506043492N2.